Primary |
Hypertonic Bladder |
37.0% |
Hypertension |
12.5% |
Urinary Incontinence |
10.4% |
Pollakiuria |
5.9% |
Bladder Disorder |
4.6% |
Incontinence |
3.5% |
Cardiac Disorder |
3.3% |
Diabetes Mellitus |
3.3% |
Blood Cholesterol Increased |
3.1% |
Micturition Urgency |
2.5% |
Depression |
2.1% |
Pain |
1.6% |
Thyroid Disorder |
1.5% |
Gastrooesophageal Reflux Disease |
1.5% |
Blood Pressure Abnormal |
1.3% |
Sleep Disorder |
1.3% |
Urge Incontinence |
1.3% |
Micturition Disorder |
1.2% |
Arthritis |
1.1% |
Hypothyroidism |
1.0% |
|
Drug Ineffective |
26.4% |
Urinary Retention |
12.9% |
Dry Mouth |
10.5% |
Vision Blurred |
5.9% |
Constipation |
5.9% |
Pollakiuria |
5.0% |
Urinary Incontinence |
4.2% |
Drug Effect Incomplete |
3.5% |
Dysuria |
2.9% |
Dizziness |
2.8% |
Rash |
2.7% |
Somnolence |
2.5% |
Headache |
2.4% |
Diarrhoea |
2.3% |
Nausea |
2.0% |
Nocturia |
1.9% |
Urinary Tract Infection |
1.7% |
Feeling Abnormal |
1.6% |
Malaise |
1.4% |
Urticaria |
1.4% |
|
Secondary |
Hypertonic Bladder |
25.4% |
Hypertension |
13.4% |
Urinary Incontinence |
11.4% |
Pollakiuria |
6.0% |
Bladder Disorder |
5.7% |
Blood Cholesterol Increased |
4.6% |
Micturition Urgency |
4.2% |
Product Used For Unknown Indication |
3.9% |
Incontinence |
3.0% |
Cardiac Disorder |
2.8% |
Gastrooesophageal Reflux Disease |
2.7% |
Depression |
2.6% |
Diabetes Mellitus |
2.3% |
Urge Incontinence |
2.2% |
Pain |
1.9% |
Blood Pressure Abnormal |
1.8% |
Thyroid Disorder |
1.8% |
Sleep Disorder |
1.4% |
Micturition Disorder |
1.4% |
Neuropathy Peripheral |
1.4% |
|
Drug Ineffective |
17.6% |
Urinary Incontinence |
13.6% |
Urinary Retention |
9.8% |
Dry Mouth |
9.5% |
Pollakiuria |
5.5% |
Vision Blurred |
5.0% |
Nausea |
4.0% |
Constipation |
3.5% |
Malaise |
3.5% |
Rash |
3.5% |
Somnolence |
3.3% |
Wrong Technique In Drug Usage Process |
3.0% |
Nocturia |
2.8% |
Pain |
2.8% |
Surgery |
2.5% |
Urine Flow Decreased |
2.5% |
Weight Increased |
2.3% |
Dysuria |
1.8% |
Gastrooesophageal Reflux Disease |
1.8% |
Glaucoma |
1.8% |
|
Concomitant |
Product Used For Unknown Indication |
37.5% |
Hypertension |
8.2% |
Multiple Sclerosis |
6.3% |
Depression |
5.3% |
Pain |
5.2% |
Osteoporosis |
3.4% |
Hypertonic Bladder |
3.2% |
Diabetes Mellitus |
3.0% |
Gastrooesophageal Reflux Disease |
3.0% |
Prophylaxis |
3.0% |
Urinary Incontinence |
2.8% |
Bladder Disorder |
2.8% |
Restless Legs Syndrome |
2.6% |
Blood Cholesterol Increased |
2.5% |
Chronic Obstructive Pulmonary Disease |
2.1% |
Micturition Urgency |
2.1% |
Drug Use For Unknown Indication |
1.9% |
Rheumatoid Arthritis |
1.8% |
Arthritis |
1.6% |
Atrial Fibrillation |
1.6% |
|
Drug Ineffective |
9.5% |
Urinary Tract Infection |
9.5% |
Pain |
7.1% |
Gastrointestinal Haemorrhage |
6.3% |
White Blood Cell Count Decreased |
5.6% |
Diarrhoea |
4.8% |
Dry Mouth |
4.8% |
Intentional Drug Misuse |
4.8% |
Multiple Sclerosis Relapse |
4.8% |
Nausea |
4.8% |
Pneumonia |
4.8% |
Death |
4.0% |
Flushing |
4.0% |
Tubulointerstitial Nephritis |
4.0% |
Vision Blurred |
4.0% |
Vomiting |
4.0% |
Weight Decreased |
4.0% |
Fall |
3.2% |
Injection Site Haematoma |
3.2% |
Memory Impairment |
3.2% |
|
Interacting |
Hypertonic Bladder |
19.5% |
Product Used For Unknown Indication |
8.9% |
Blood Pressure Abnormal |
8.1% |
Blood Cholesterol Increased |
7.3% |
Urinary Incontinence |
6.5% |
Bipolar Disorder |
4.9% |
Erectile Dysfunction |
4.9% |
Atrial Fibrillation |
4.1% |
Hypertension |
4.1% |
Anxiety |
3.3% |
Blood Pressure Increased |
3.3% |
Dementia Alzheimer's Type |
3.3% |
Depression |
3.3% |
Fibromyalgia |
3.3% |
Micturition Disorder |
3.3% |
Type 2 Diabetes Mellitus |
3.3% |
Diabetes Mellitus |
2.4% |
Sleep Disorder |
2.4% |
Urinary Tract Disorder |
2.4% |
Arthritis |
1.6% |
|
Drug Interaction |
25.0% |
Urinary Retention |
9.1% |
Libido Disorder |
6.8% |
Urine Odour Abnormal |
6.8% |
Confusional State |
4.5% |
Dry Mouth |
4.5% |
Mania |
4.5% |
Pain |
4.5% |
Pruritus |
4.5% |
Rash |
4.5% |
Vision Blurred |
4.5% |
Drug Ineffective |
2.3% |
Electrocardiogram Qt Prolonged |
2.3% |
Fatigue |
2.3% |
Hyperhidrosis |
2.3% |
Memory Impairment |
2.3% |
Nausea |
2.3% |
Pollakiuria |
2.3% |
Somnolence |
2.3% |
Urinary Hesitation |
2.3% |
|